Skip to main content
Link to Walkers homepage

Capital treatment for Bermuda insurers investing in structured assets

Mar 18, 2026

Advisory
Shades of blue —light, medium, and dark—displayed curves and waves

Key takeaways

  • With the rise of insurer investment in alternative capital structures, we explore the two-step analysis required for efficient Bermuda capital treatment.
  • An asset that appears efficient under the Bermuda Solvency Capital Requirement (BSCR) can still create challenges once liability fit and asset liability management (ALM) are tested.
  • Labels and ratings do not finish the inquiry as the Bermuda Monetary Authority (BMA) focuses on substance, look-through, collateral quality, liquidity and the strength of the evidence supporting the underlying structure.

Why sophisticated Asset-Backed Securities (ABS), Funding Agreement-Backed Notes (FABNs), Rated Note Feeders and related alternative capital structures require a two-step analysis across the balance sheet of a Bermuda insurer

The capital question is not one question

A structure that looks attractive on the asset side does not automatically produce a durable Bermuda outcome. The real work is often bifurcated between asset-side BSCR treatment and liability-side implications for reserving, discounting and ALM.

What clients should know

Not just a label: A bond wrapper, note format or marketing description does not end the inquiry. Bermuda analysis turns on the substance of the exposure and the build of the asset.

Ratings help, but proof still matters:
Ratings can be important, but so are look-through, liquidity, concentration, governance, conflicts and the quality of the supporting evidence package.

Two steps, not one:
A structure may appear efficient on the asset side and still create friction when tested against liability methodology, discounting assumptions and the strength of the ALM narrative.

The two-step Bermuda analysis

Step 1. Asset-side review under the BSCR

  • How is the exposure classified in substance?
  • Is look-through required, expected or commercially prudent?
  • How robust is the rating analysis and downside story?
  • What do liquidity, concentration and related-party features do to the capital thesis?
  • Does the structure invite a higher evidentiary or approval burden?

Step 2. Liability-side review

  • How does the asset interact with best estimate liabilities and risk margin?
  • Is the case being run under the Standard Approach or with Scenario-Based Approach (SBA) ambitions?
  • Do the asset cash flows genuinely support the liability profile?
  • How resilient is the matching story under stress, runoff and dislocation?
  • Do the documents including the investment guidelines support the capital outcome being claimed?

Where sponsor assumptions often breakdown with structured assets 

How we help

  • Early-stage regulatory triage before term sheets harden.
  • Pressure-testing of ABS, FABNs, RNFs and related structures across both sides of the balance sheet.
  • Identification of issues likely to matter to boards, risk functions and supervisors.
  • Coordination of transaction, regulatory and Bermuda law workstreams.
  • Targeted support for sponsor, insurer and counterparty messaging.
  • Practical framing that highlights where bespoke legal advice adds real value.
     

Further information on Bermuda capital treatment for structured assets

The goal is not a theoretical capital answer. It is a Bermuda outcome that remains defensible to the regulator, the board and the deal team at the same time.

For more information, please get in touch with your usual contact at Walkers or any of the individuals in your region listed below.

InsuranceRegulatory & ComplianceBermuda

Authors

Sarah Demerling

Sarah Demerling

Partner/Bermuda

T/+1 441 242 1525
M/+1 441 525 1525
E/Email Sarah Demerling
More articles from this author View profile
Nathalie West

Nathalie West

Partner/Bermuda

T/+1 441 242 1523
M/+1 441 525 1523
E/Email Nathalie West
More articles from this author View profile

Gary Harris

Partner/Cayman Islands

T/+1 345 814 7602
M/+1 345 936 7602
E/Email Gary Harris
More articles from this author View profile

Key contacts

Get in touch with our team

Sarah Demerling
Sarah Demerling

Sarah Demerling

Partner

Bermuda

T

+1 441 242 1525

M

+1 441 525 1525

E

Email Sarah Demerling
View profile
Nathalie West
Nathalie West

Nathalie West

Partner

Bermuda

T

+1 441 242 1523

M

+1 441 525 1523

E

Email Nathalie West
View profile
Gary Harris

Gary Harris

Partner

Cayman Islands

T

+1 345 814 7602

M

+1 345 936 7602

E

Email Gary Harris
View profile

Get the latest insights and expertise in your inbox 

Fluid ink image
Sign up
logo footer

Connect with us

FacebookFacebook
InstagramInstagram
LinkedInLinkedIn

Employee login

Self Service Password ResetWalkers AnywhereWalkers Sharefile
Legal notices/Cookies policy

All rights reserved - © 2026 Walkers Global